Anti-allergic effects of Artemisia iwayomogi on mast cell-mediated allergy model

Experimental Biology and Medicine

Volumn 230, Issue 1, 2005, Pages 82-88

  Kim, Sang Hyun ^a   Choi, Cheol Hee ^a   Kim, Sang Yong ^b   Eun, Jae Soon ^c   Shin, Tae Yong ^c  

^a Chosun University   (South Korea)

^b Korea National Arboretum   (South Korea)

^c Woosuk University   (South Korea)

Author keywords

Artemisia iwayomogi; Interleukin 6; Intracellular Ca2+; Mast cells; Nuclear factor B; p38 mitogen activated protein kinase; Tumor necrosis factor

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTIALLERGIC AGENT; ARTEMISIA IWAYOMOGI EXTRACT; CALCIMYCIN; CALCIUM IONOPHORE; I KAPPA B ALPHA; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 12 ACETATE 13 MYRISTATE; PLANT EXTRACT; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLERGY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTEMISIA; ARTEMISIA IWAYOMOGI; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; HISTAMINE RELEASE; HUMAN; HUMAN CELL; MALE; MAST CELL; MOUSE; NONHUMAN; PASSIVE SKIN ANAPHYLAXIS; PERITONEUM MAST CELL;

ANIMALIA; ARTEMISIA; ARTEMISIA IWAYOMOGI; ASTERACEAE;

EID: 11144252694     PISSN: 15353702     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020523000111     Document Type: Article

References (33)

1. Lee KR, Zee OP, Kwak JH, Kim YS, Park HK, Koo KA, Youn HJ. The polysaccharide fractions of Artemisia species. Kor J Pharmacogn 24:289-295, 1993.
2. Kang CK, Yook CS, Han DR. Studies on the constituents of herbs, roots and flowers in Artemisia iwayomogi. Bull Pharm Sci 21:39-43, 1993.
3. Church MK, Levi-Schaffer F. The human mast cell. J Allergy Clin Immunol 99:155-160, 1997.
4. Metcalfe DD, Kaliner M, Donlon MA. The mast cell. Crit Rev Immunol 3:23-74, 1981.
5. Miyajima I, Dombrowicz D, Martin TR, Ravetch JV, Kinet JP, Galli, SJ. Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gammaRIII: assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis. J Clin Invest 99:901-914, 1997.
6. Petersen LJ, Mosbech H, Skov PS. Allergen-induced histamine release in intact human skin in vivo assessed by skin microdialysis technique: characterization of factors influencing histamine release ability. J Allergy Clin Immunol 97:672-679, 1996.
7. Ennis M, Pearce FL, Weston PM. Some studies on the release of histamine from mast cells stimulated with polylysine. Br J Pharmacol 70:329-334, 1980.
8. Beaven MA, Metzger H. Signal transduction by Fc receptors: the Fc epsilon RI case. Immunol Today 14:222-226, 1993.
9. Beaven MA, Rogers J, Moore JP, Hesketh TR, Smith GA, Metcalfe JC. The mechanism of the calcium signal and correlation with histamine release in 2H3 cells. J Biol Chem 259:7129-7136, 1984.
10. Bradding P, Feather IH, Wilson S, Bardin PG, Heusser CH, Holgate ST, Howarth PH. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects: the mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. J Immunol 151:3853-3865, 1993.
11. Burd PR, Rogers HW, Gordon JR, Martin CA, Jayaraman S, Wilson SD, Dvorak AM, Galli SJ, Dorf ME. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med 170:245-257, 1989.
12. Plaut M, Pierce JH, Watson CJ, Hanley-Hyde J, Nordan RP, Paul WE. Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature 339:64-67, 1989.
13. Baldassare JJ, Bi Y, Bellone CJ. The role of p38 mitogen-activated protein kinase in IL-1 beta transcription. J Immunol 162:5367-5373, 1999.
14. Beyaert R, Cuenda A, Vanden Berghe W, Plaisance S, Lee JC, Haegeman G, Cohen P, Fiers W. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J 15:1914-1923, 1996.
15. Azzolina A, Bongiovanni A, Lampiasi N. Substance P induces TNF-alpha and IL-6 production through NF kappa B in peritoneal mast cells. Biochim Biophys Acta 1643:75-83, 2003.
16. Shin TY, Kim SH, Choi CH, Shin HY, Kim HM. Isodon japonicus decreases immediate-type allergic reaction and tumor necrosis factor-alpha production. Int Arch Allergy Immunol 29:17-23, 2004.
17. Shore PA, Burkhalter A, Cohn VH Jr. A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther 127:182-186, 1959.
18. Yurt RW, Leid RW Jr, Austen KF. Native heparin from rat peritoneal mast cells. J Biol Chem 252:518-521, 1977.
19. Kim SH, Sharma RP. Mercury-induced apoptosis and necrosis in murine macrophages: role of calcium-induced reactive oxygen species and p38 mitogen-activated protein kinase signaling. Toxicol Appl Pharmacol 196:47-57, 2004.
20. Kim SH, Johnson VJ, Shin TY, Sharma RP. Selenium attenuates lipopolysaccharide-induced oxidative stress responses through modulation of p38 MAPK and NF-kappaB signaling pathways. Exp Biol Med 229:203-213, 2004.
21. Sillaber C, Bevec D, Butterfield JH, Heppner C, Valenta R, Scheiner O, Kraft D, Lechner K, Bettelheim P, Valent P. Tumor necrosis factor alpha and interleukin-1 beta mRNA expression in HMC-1 cells: differential regulation of gene product expression by recombinant interleukin-4. Exp Hematol 21:1271-1275, 1993.
22. Kemp SF, Lockey RF. Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol 110:341-348, 2002.
23. Mousli M, Bronner C, Landry Y, Bockaert J, Rouot B. Direct activation of GTP-binding regulatory proteins (G-proteins) by substance P and compound 48/80. FEBS Lett 259:260-262, 1990.
24. Tasaka K, Mio M, Okamoto M. Intracellular calcium release induced by histamine releasers and its inhibition by some antiallergic drugs. Ann Allergy 56:464-469, 1986.
25. Alfonso A, Cabado AG, Vieytes MR, Botana LM. Functional compartments in rat mast cells for cAMP and calcium on histamine release. Cell Signal 12:343-350, 2000.
26. Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF. Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci U S A 88:4220-4224, 1991.
27. Mican JA, Arora N, Burd PR, Metcalfe DD. Passive cutaneous anaphylaxis in mouse skin is associated with local accumulation of interleukin-6 mRNA and immunoreactive interleukin-6 protein. J Allergy Clin Immunol 90:815-824, 1992.
28. Jeong HJ, Hong SH, Lee DJ, Park JH, Kim KS, Kim HM. Role of Ca(2+) on TNF-alpha and IL-6 secretion from RBL-2H3 mast cells. Cell Signal 14:633-639, 2002.
29. Manthey CL, Wang SW, Kinney SD, Yao Z. SB202190, a selective inhibitor of p38 mitogen-activated protein kinase, is a powerful regulator of LPS-induced mRNAs in monocytes. J Leukoc Biol 64:409-417, 1998.
30. Shapiro L, Dinarello CA. Osmotic regulation of cytokine synthesis in vitro. Proc Natl Acad Sci U S A 92:12230-12234, 1995.
31. Kim AR, Zou YN, Park TH, Shim KH, Kim MS, Kim ND, Kim JD, Bae SJ, Choi JS, Chung HY. Active components from Artemisia iwayomogi displaying ONOO(-) scavenging activity. Phytother Res 18:1-7, 2004.
32. Yu HH, Kim YH, Kil BS, Kim KJ, Jeong SI, You YO. Chemical composition and antibacterial activity of essential oil of Artemisia iwayomogi. Planta Med 69:1159-1162, 2003.
33. Shin BK, Lee EH, Kim HM. Suppression of L-histidine decarboxylase mRNA expression by methyleugenol. Biochem Biophys Res Commun 232:188-191, 1997.